Pharmaceutical Raw Materials
Veterinary API
Antiallergic Drugs
Hormones and Endocrine Drugs
Drug Metabolism
Pharmaceutical Intermediates
Synthetic Anti Infective Drugs
Specialty Drugs
Vitamins and Minerals Medicines
Feed Drug Additive
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Diagnostic Agents
Anti Stress Drugs
Antipyretic Analgesics
Antiparasitic Drugs
Circulatory System Drugs
Biochemicals
Blood System Drugs
Immune System Medication
Pharmaceutical Excipients
Fluid, Electrolyte, and Acid-Base Balance
Urinary System Drugs
Antibiotics
Anesthetic Agents
Inhibitors
Other Chemical Drugs
Digestive System Drugs
CAS:2338-21-8
Molecular Formula:C18H23IN2S
Brief Introduction
Thiazinamium metilsulfate (INN) or thiazinam is an antihistamine. The USAN is thiazinamium chloride (with a different counterion).
CAS:2338-37-6
Molecular Formula:C22H29NO2
Alias
More Information
L-Proline Ethyl Ester Monohydrochloride; L-Proline Ethyl Ester Hydrochloride; Ethyl L-Prolinate Hcl; L-Propoxyphen; Ethyl L-Prolinate Hydrochloride; L-Pro-Oet*Hcl; L-Propoxyphene; S-Proline Ethyl Ester Hydrochloride; Benzeneethanol, A-[(1S)-2-(Dimethylamino)-1-Methylethyl]-A-Phenyl-, 1-Propanoate, (Ar)-; Levopropoxifeno; Levopropossifene
Brief Introduction
Levopropoxyphene is an antitussive. It is an optical isomer of dextropropoxyphene. The racemic mixture is called propoxyphene. Only the dextro-isomer (dextropropoxyphene) has an analgesic effect; the levo-isomer appears to exert only an antitussive effect. It was formerly marketed in the U.S. by Eli Lilly under the tradename Novrad (a reversal of Darvon) as an antitussive.
CAS:235114-32-6
Molecular Formula:C56H71N9O23S
Brief Introduction
The recommended dose for the treatment of esophageal candidiasis is 150mg per day, and the recommended dose for the prevention of Candida infection in hematopoietic stem cell transplantation patients is 50mg per day. According to the available clinical data, the average course of treatment or prevention of the above two diseases is 15 days and 19 days respectively. The medicinal normal saline or 5% glucose injection is prepared and diluted. The administration time shall be at least 1 hour, otherwise it is easy to produce adverse reactions.
Alias
More Information
Decanone; 6-Gingerol; (S)-5-Hydroxy-1-(4-Hydroxy-3-Methoxyphenyl)Decan-3-One; 3-Decanone (5-Hydroxy-1-(4-Hydroxy-3-Methoxyphenyl); (S)-5-Hydroxy-1-(4-Hydroxy-3-Methoxyphenyl)-3-Decanone; (5S)-5-Hydroxy-1-(4-Hydroxy-3-Methoxyphenyl)Decan-3-One; 1-(4'-Hydroxy-3'-Methoxyphenyl)-5-Hydroxy-3-; [6]-Gingerol, Zingiber Officinale; (5S)-5-Hydroxy-1-(4-Hydroxy-3-Methoxy-Phenyl)Decan-3-One; (S)-5-Hydroxy-1-(4-Hydroxy-3-Methoxy-Phenyl-3-Decanone; 5-Hydroxy-1-(4'-Hydroxy-3'-Methoxyphenyl)-3-Decanone
Brief Introduction
This product is a bioactive compound with antioxidant activity. It is an anti-inflammatory and anti-tumor drug.
CAS:23602-78-0
Molecular Formula:C19H21ClF3NO2
Alias
More Information
1-(3-Trifluoromethylphenyl)-2-(-2-Benzoyloxyethylamino)Propane; Benflurex; Mediaxal; Jp992; 1-(3-Trifluormethylphenyl)-2-(2-Benzoyloxyethylamino)-Propan; Minolip; S780; S992; Se780; Benfluramate; Mediator
Brief Introduction
Benfluorex is an anorectic and hypolipidemic agent that is structurally related to fenfluramine. It was patented and manufactured by a French pharmaceutical company Servier. The European Medicines Agency (EMA) recommended withdrawing all benfluorex containing medicines on 18 December 2009. This recommendation was based on the risks (especially fenfluramine-like cardiovascular side-effects) outweighing the benefits.
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!